Heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Analog of the tetrapeptide tuftsin |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Reported consistently across pharmacopoeial descriptions |
| Appearance | White to off-white lyophilized powder | Typical form of research-grade material |
| Solubility | Freely soluble in water | Aqueous buffers; poor in nonpolar solvents |
| Typical storage temperature | -20 degrees Celsius | Lyophilized powder; protect from moisture |
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Michael T. Longaker is an American medical researcher and board-certified plastic surgeon. He has been a member of the Stanford Diabetes Research Center since 2018. He is the Deane P. and Louise Mitchell Professor for Plastic and Reconstructive Surgery, and by courtesy a Professor of Materials Science and Engineering. He is a co-founder of the medical research venture capital fund TauTona Group, as well as of biotechnology companies Arresto Biosciences and Neodyne Biosciences.
=== Internal organizations of the council === Office Research Room Human Resources Department Economic Development and Reform Department Finance and Accounting Department (Office of the Social Assets Management Committee) Cooperation Guidance Department (Legal Work Office) Financial Services Department International Cooperation Department Science and Education Club Department Agricultural Production Materials and Cotton and Hemp Bureau Party Committee of Directly Affiliated Organs Supervisory bureau Audit Bureau Retired Cadres Department
In July, the chief administrator of the Environmental Protection Agency announced rescinding of the 2009 endangerment finding, which concluded that planet-warming greenhouse gases pose a threat to public health. (The endangerment finding is the scientific determination that underpins the federal government's legal authority to combat climate change.) In concurrence with the attempt to rollback the endangerment finding, Trump's Department of Energy released an assessment titled A Critical Review of Impacts of Greenhouse Gas Emissions on the U.S. Climate. The report was assembled by five climate science contrarians and was heavily criticized for cherry-picked evidence, falsehoods, and distortions. The Union of Concerned Scientists called it "deeply flawed [and] anti-science". Climate scientist Andrew Dessler called it "a mockery of science". On February 12, 2026, the EPA formally rescinded the Endangerment Finding. In August 2025, the Bureau of Land Management initiated a review of offshore wind energy regulations and revised its rules to favor fossil fuel production over renewables. On September 23, 2025, Trump told the United Nations General Assembly that climate change is "the greatest con job ever perpetrated on the world", that scientific predictions "were made by stupid people", and that renewable energy is a "scam". In October 2025, the Department of Energy cancelled 321 clean energy grants, totaling $7.56 billion, issued in the Biden administration.
Chitosan is a linear polysaccharide composed of randomly distributed β-(1→4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). It is made by treating the chitin shells of shrimp and other crustaceans with an alkaline substance, such as sodium hydroxide. Chitosan has a number of commercial and possible biomedical uses. It can be used in agriculture as a seed treatment and biopesticide, helping plants to fight off fungal infections. In winemaking, it can be used as a fining agent, also helping to prevent spoilage. In industry, it can be used in a self-healing polyurethane paint coating. In medicine, it is useful in bandages (in the form of chitosan hydrocolloid dressing) to reduce bleeding and as an antibacterial agent; it can also be used to help deliver drugs through the skin.
Sources: en.wikipedia.org
Agarose is a preferred matrix for work with proteins and nucleic acids as it has a broad range of physical, chemical and thermal stability, and its lower degree of chemical complexity also makes it less likely to interact with biomolecules. Agarose is most commonly used as the medium for analytical scale electrophoretic separation in agarose gel electrophoresis. Gels made from purified agarose have a relatively large pore size, making them useful for separation of large molecules, such as proteins and protein complexes >200 kilodaltons, as well as DNA fragments >100 basepairs. Agarose is also used widely for a number of other applications, for example immunodiffusion and immunoelectrophoresis, as the agarose fibers can function as anchor for immunocomplexes.
Algaecide or algicide is a biocide used for killing and preventing the growth of algae, often defined in a loose sense that, beyond the biological definition, also includes cyanobacteria ("blue-green algae"). An algaecide may be used for controlled bodies of water (reservoirs, golf ponds, swimming pools), but may also be used on land for locations such as turfgrass.
The party would also view winning a majority of Scotland's seats at Westminster as a mandate to begin independence negotiations. Labour suspends Andy Brown, its candidate for Aberdeenshire North and Moray East after he was found to have shared pro-Russian posts online. The Scottish Family Party launches its election manifesto, chiefly promoting family values. 20 June – Scottish Parliament authorities have launched an investigation into the potential misuse of expenses to buy postage stamps by members of the SNP in order to send letters to voters. The GMB announces a series of strikes for staff at Whyte & Mackay beginning on 24 June after staff at the whisky distillery rejected the company's latest pay offer. Police remove a group of 26 men from an EasyJet flight at Glasgow Airport over disruptive behaviour. 23 June – Scotland exit Euro 2024 at the group stage after losing 1–0 to Hungary. 24 June – Scottish wildcat kittens have been born in the Cairngorms National Park, in a "major milestone" for the conservation of the Critically Endangered species. The Scottish Conservatives launch their election manifesto, which includes plans to improve teachers' pay, cut the backlog of NHS waiting lists, and to beat the SNP. 25 June – The body of missing grandmother Hazel Nairn is identified after she went missing in floods at the River Don, near Monymusk, in November 2022. Her remains were discovered near Kemnay on 7 May. 26 June – It is announced that the results of the 2022 Scottish Census will contain a breakdown of the country's LGBTQ community for the first time.
== History == Iso-LSD was first described in the scientific literature, by Albert Hofmann and colleagues, in the 1940s. The psychedelic effects of LSD were discovered by Hofmann in 1943 when he was using column chromatography to separate LSD from iso-LSD that had resulted as an impurity during the synthesis of LSD.
Oxytocin administered orally produces different effects on human behaviour and brain function than when given intranasally, possibly due to variations in the molecular transport and binding mechanisms.
Sources: en.wikipedia.org
==== Central core disease ==== Central core disease or central core myopathy was first described in 1956 and usually presents in infancy or early childhood as non-progressive mild proximal weakness that persists throughout life. Central core disease is believed to be more prevalent than currently reported, as it is hard to recognize and often misdiagnosed in early childhood. Central core disease has been found to be allelic with malignant hyperthermia, which is a life-threatening anesthetic reaction that causes a rise in body temperature, muscular rigidity and muscular breakdown, grossly elevated creatine kinase, and acidosis. Central core disease is caused by a mutation in the RYR1 gene.
==== 2800–2899 ==== Scottish Electricity Boards (Dissolution) Order 1993 (S.I. 1993/2802) Road Traffic Act 1991 (Commencement No. 8 and Transitional Provisions) Order 1993 (S.I. 1993/2803) Road Traffic (Special Parking Areas) (London Boroughs of Camden, Hackney and Hounslow) Order 1993 (S.I. 1993/2804) Meldon Quarry Branch Line Order 1993 (S.I. 1993/2805) Foreign Compensation (Financial Provisions) (No. 2) Order 1993 (S.I. 1993/2806) Libya (United Nations Sanctions) Order 1993 (S.I. 1993/2807) Libya (United Nations Sanctions) (Dependent Territories) Order 1993 (S.I. 1993/2808) State Immunity (Federal States) Order 1993 (S.I. 1993/2809) Education and Libraries (Northern Ireland) Order 1993 (S.I. 1993/2810) Libya (United Nations Sanctions) (Channel Islands) Order 1993 (S.I. 1993/2811) Libya (United Nations Sanctions) (Isle of Man) Order 1993 (S.I. 1993/2812) Local Government Act 1988 (Defined Activities) (Exemption) (Wales) Order 1993 (S.I. 1993/2813) British Railways (Penalty Fares) Act 1989 (Activating No. 11) Order 1993 (S.I. 1993/2814) Central Manchester National Health Service Trust (Change of Name) Order 1993 (S.I. 1993/2815) Cleveland Ambulance National Health Service Trust (Establishment) Amendment Order 1993 (S.I. 1993/2816) Education (School Information) (Amendment) (England) Regulations 1993 (S.I. 1993/2824) Area Boards (Dissolution) Order 1993 (S.I. 1993/2825) Collecting Societies (Returns) Regulations 1993 (S.I. 1993/2826) Education (No. 2) Act 1986 (Amendment) (No. 2) Order 1993 (S.I. 1993/2827) Education (Recognised Awards) (Richmond College) Order 1993 (S.I.
Minnich, V.; Na-Nakorn, S.; Chong-Chareonsuk, S.; Kochaseni, S. (January 1954). "Mediterranean anemia; a study of thirty-two cases in Thailand". Blood. 9 (1): 1–23. doi:10.1182/blood.V9.1.1.1. ISSN 0006-4971. PMID 13115468. Chernoff, Amoz I.; Minnich, Virginia; Chongchareonsuk, Soodsarkorn (1954). "Hemoglobin E, a Hereditary Abnormality of Human Hemoglobin". Science. 120 (3120): 605–606. Bibcode:1954Sci...120..605C. doi:10.1126/science.120.3120.605. JSTOR 1682300. PMID 13205193. Pica
===== Treatment ===== Because there are no medications with an approved indication for cocaine use disorder, psychosocial treatments are the current standard. Effective approaches include group and individual counseling, cognitive behavioral therapy (CBT), and motivational interviewing (MI). Contingency management (CM)—which rewards patients with vouchers for meeting treatment goals—has proven especially effective, particularly for helping patients achieve initial abstinence from cocaine.
Sources: en.wikipedia.org
Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.
The first four residues of Selank reproduce the tuftsin sequence Thr-Lys-Pro-Arg. A Pro-Gly-Pro extension at the C-terminus was added to slow enzymatic breakdown and extend residence time.
It holds marketing authorization in Russia, where nasal drop formulations are sold. No equivalent approval exists in the European Union, the United States, or most other countries.
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.